Cutting cancer costs is a worthy policy, but we must try to prevent it too

Removing the financial worries from Australians diagnosed with cancer is bound to be a popular move.
The Opposition’s $2.3 billion cancer care plan – announced in Bill Shorten’s budget reply speech on Thursday night – aims to ensure cancer treatment costs for scans, specialists and drugs are bulk billed or subsidised under the Pharmaceutical Benefits Scheme (PBS).
It would be a hard heart indeed that did not welcome such a move.
Maybe even better than avoiding the out-of-pocket costs of treatment is preventing future cases of cancer.